Weight Has Strongest Effect On Hormones That Raise Breast Cancer Risk
7/21/2011
Weight has the strongest effect on the sex hormones that increase breast cancer risk in post menopausal women, according to new research published in the British Journal of Cancer this week...
ACR, SBI Support Updated ACOG Recommendations That Women Begin Annual Mammograms At Age 40
7/21/2011
The American College of Radiology (ACR) and Society of Breast Imaging applaud and support updated American College of Obstetricians and Gynecologists' (ACOG) recommendations that women begin getting annual mammograms at age 40...
Evolution Provides Clue To Blood Clotting
7/21/2011
A simple cut to the skin unleashes a complex cascade of chemistry to stem the flow of blood. Now, scientists at Washington University School of Medicine in St. Louis have used evolutionary clues to reveal how a key clotting protein assembles. The finding sheds new light on common bleeding disorders...
Schools Failing Pupils With Sickle Cell Disease
7/21/2011
A new study suggests young people with a serious genetic blood disorder are not getting the right help at school, especially pupils who miss lessons due to sickness...
During the 14th World Conference on Lung Cancer, leading users of Elekta Stereotactic Body Radiation Therapy (SBRT) technology presented their findings on the use of SBRT to treat early stage, non-small cell lung cancer (NSCLC). The most common form of lung cancer, NSCLC arises from a number of causes, including active smoking, passive smoking (secondhand smoke), and exposure to other carcinogens...
Hormone Therapy Post Chemo Aids Menstrual Cycles In Cancer Victims
7/20/2011
Chemotherapy is often a last resort to treating breast cancer, and in at least 40% of those women, menstrual cycles are effected including the complete absence of menstruation. New research shows that temporarily suppressing ovarian function with use of the hormone analogue triptorelin reduced the occurrence of early menopause induced by chemotherapy among women with breast cancer...
A major challenge for cancer biologists is figuring out which among the hundreds of genetic mutations found in a cancer cell are most important for driving the cancer's spread...
Researchers Able To Precisely Simulate The Inhibition Of Genes With New Cancer Drugs
7/20/2011
Only one in twenty cancer drugs makes its way from the laboratory to become an approved pharmaceutical product. The majority of new agents are only shown to be unsuitable in the later phases of clinical development which would explain the exorbitantly high development costs of 500 to 600 million euros per new cancer drug...
Researchers Discover Possible Drug Targets For Common Non-Hodgkin's Lymphoma
7/20/2011
Researchers at the University of Maryland School of Medicine have discovered a novel interaction between two proteins involved in regulating cell growth that could provide possible new drug targets for treating diffuse large B-cell lymphoma, the most common type of non-Hodgkin's lymphoma...
Some Cutaneous HPV Types May Be Involved In Non-Melanoma Skin Cancer Development
7/20/2011
Non-melanoma skin cancer is the most common form of malignancy in adult Caucasian populations, with more than a million cases recorded each year in the USA alone. Lifestyle risk factors...